You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Web-based High School Media Literacy for Healthy Relationships

    SBC: Innovation Research And Training, Inc.            Topic: NICHD

    Project Abstract Adolescents can benefit greatly from evidence basedmedically accurate sexual and relationship health educationHoweverboth teachers and parents face challenges in effectively teaching about sexual health and relationships leading to students receiving incomplete or inaccurate informationYoung people turn to the media for informationand many media messages about sex and relationship ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Validation of a Performance Based Measure of Functioning in MCI and Early AD

    SBC: NEUROCOG TRIALS            Topic: NIA

    Project SummaryAlzheimer s diseaseADis expected to rise in prevalence fromtomillion Americans byleading toof deaths among adults overThis epidemic is projected to overwhelm healthcare and economic resourceswith costs reaching $billion in the US inand $trillion byThere is no cure for ADand no new drugs have been successful in treating the advanced stages of AD related dementiaA growing body of rese ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  3. THERMOSYPHON TARGETRY TO IMPROVE F-18 PET

    SBC: Bruce Technologies, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall objective of the proposed work is to reduce the cost of accelerator produced F-18 radiopharmaceuticals used in Positron Emission Tomography (PET), a Medicare-reimbursed nuclear medicine metabolic imaging modality used to diagnose, stage, and restage ten cancer indications. Annual PET scans (350,000+) are rapidly increasing, but CMS reimbursement ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Therapeutic for the Negative Symptoms of Schizophrenia

    SBC: Darpharma, Inc.            Topic: N/A

    DESCRIPTION (PROVIDED BY APPLICANT): Schizophrenia affects roughly 1% of the world's population, with more than two million Americans afflicted in any given year, and an estimated 30-50 million people worldwide. Treatment with available antipsychotic medications often effectively attenuates the positive symptoms of schizophrenia without improvement in the negative symptoms or cognitive deficits. F ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Testing a male oral contraceptive targeting Eppin

    SBC: Eppin Pharma Inc            Topic: NICHD

    The global contraceptives market was valued at $billion inand is expected to grow at a CAGR offromtoto reach an estimated value of $billion inThe contraceptive market consists of short term methods such as condoms and oral contraceptionlong term methods including implants and IUDsand permanent methods such as tubal ligations and vasectomiesEppin Pharmaandapos s product has a unique set of characte ...

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Targeting leukocyte metabolism to treat human autoimmune disease

    SBC: Immunext, Inc.            Topic: R

    ImmuNext has defined an anti-MCT1 monoclonal antibody (mAb) that will be developed for the treatment of human autoimmune disease. The membrane monocarboxylate nutrient transporter SLC16A1 (MCT1) is a multi-pass transmembrane protein responsible for the facilitated transport of critical metabolites, including products of glycolysis: lactate, pyruvate and ketones. Our strong preliminary data support ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Synthesis and Evaluation of a Novel Anti-HIV Agent

    SBC: Kucera Pharmaceutical Company            Topic: N/A

    The long-term goal of this research is to develop a drug that is safe and effective against drug-resistant human immunodeficiency virus (HIV) infection. Several challenges confront current anti-HIV chemotherapy. The frequency of drug-resistant and multidrug-resistant HIV-1 is increasing. Toxicities associated with current HIV medications often result in the discontinuation of these therapies. Phys ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Substance Abuse Prevention Media Literacy Curriculum

    SBC: Innovation Research And Training, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): In response to published NIDA research topics calling for innovation in educational programs aimed at substance abuse prevention, the proposed project will develop and empirically tested media literacy alcohol and tobacco use prevention curriculum with use with children in grades three through five. The curriculum will contain goals, lesson plan scripts and act ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  9. STEM Interactive Digital Tool to Educate and Promote Hearing Health and Science for 4th to 7th Grade

    SBC: CREARE LLC            Topic: 500

    PROJECT SUMMARY ABSTRACT The National Research Council recognizes that serious computer games can support new inquiry based approaches to science instructionproviding virtual laboratories or field learning experiences that overcome practical and logistical constraints to student investigationsWith the nationally recognized need to encourage and enhance education in the ScienceTechnologyEngineering ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Silicone-Free Low Friction Coating for Syringes

    SBC: Tribofilm Research, Inc.            Topic: N/A

    This proposal outlines the final steps in achieving the successful commercial qualification of the Tribo-Glide? high performance non-silicone lubricant system developed in Phase I and Phase II for syringes and medical devices. Achievement of regulatory approval of the non-silicone lubricant system applied to disposable glass-clear COG syringes will open the door for numerous drug companies to inco ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government